![](https://www.rdworldonline.com/wp-content/uploads/2024/08/tirzepatide-1.jpg)
This week in R&D: Eli Lilly eyes $1,000 share price while pharma overall cuts back on R&D
The R&D World Index (RDWI) climbed 2.57% this week, with Eli Lilly leading the charge at a 10.84% gain, while tech giants ramp up AI investments amidst regulatory challenges. In the week ending August 9, 2024, the index closed at 3768.96 for the 25 …